Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy (CRT) in muscle-invasive urothelial carcinoma of bladder (MIBC): A combined retrospective analysis of two prospective studies.

被引：0
|
作者：
Hong, Joohyun
Choi, Daeho
Sung, Hyun Hwan
Jeong, Byong Chang
Park, Se Hoon
机构：
[1] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Samsung Med Ctr,Sch Med, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pathologic down-staging and complete pathologic response with gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder
    Psutka, Sarah P.
    Olumi, Aria F.
    Feldman, Adam S.
    Saylor, Philip James
    Kaufman, Donald S.
    Lee, Richard J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [42] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Hiromi Murasawa
    Takuya Koie
    Chikara Ohyama
    Hayato Yamamoto
    Atsushi Imai
    Shingo Hatakeyama
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Ikuya Iwabuchi
    Masaru Ogasawara
    Toshiaki Kawaguchi
    International Journal of Clinical Oncology, 2017, 22 : 159 - 165
  • [43] The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
    Murasawa, Hiromi
    Koie, Takuya
    Ohyama, Chikara
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Iwabuchi, Ikuya
    Ogasawara, Masaru
    Kawaguchi, Toshiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (01) : 159 - 165
  • [44] NEOADJUVANT GEMCITABINE AND CARBOPLATIN FOLLOWED BY IMMEDIATE RADICAL CYSTECTOMY FOR MUSCLE-INVASIVE BLADDER CANCER PATIENTS INELIGIBLE FOR CISPLATIN-BASED CHEMOTHERAPY: A PROPENSITY SCORE-MATCHED ANALYSIS
    Koie, Takuya
    Ohyama, Chikara
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    JOURNAL OF UROLOGY, 2016, 195 (04): : E668 - E668
  • [45] Neoadjuvant gemcitabine and carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy: A propensity score-matched analysis
    Koie, Takuya
    Ohyama, Chikara
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [46] Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer
    Kitagawa, Yasuhide
    Izumi, Komi
    Miwa, Sotaro
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANTICANCER RESEARCH, 2013, 33 (10) : 4497 - 4503
  • [47] Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
    Pietzak, Eugene J.
    Zabor, Emily C.
    Bagrodia, Aditya
    Armenia, Joshua
    Hu, Wenhuo
    Zehir, Ahmet
    Funt, Samuel
    Audenet, Francois
    Barron, David
    Maamouri, Noelia
    Li, Qiang
    Teo, Min Yuen
    Arcila, Maria E.
    Berger, Michael F.
    Schultz, Nikolaus
    Dalbagni, Guido
    Herr, Harry W.
    Bajorin, Dean F.
    Rosenberg, Jonathan E.
    Al-Ahmadie, Hikmat
    Bochner, Bernard H.
    Solit, David B.
    Iyer, Gopa
    EUROPEAN UROLOGY, 2019, 75 (02) : 231 - 239
  • [48] Tumor infiltrating lymphocytes (TIL) assessment in muscle invasive bladder cancer (MIBC) patients treated with cisplatin-based neoadjuvant chemotherapy (NAC) and surgery
    Chanza, Nieves Martinez
    Hamid, Anis
    Salgado, Roberto
    Gevaert, Thomas
    Maetens, Marion
    Rorive, Sandrine
    Aftimos, Philippe Georges
    Sideris, Spyridon
    Gil, Thierry
    Awada, Ahmad
    Roumeguere, Thierry Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] Muscle invasive bladder cancer (MIBC) demonstrates neoadjuvant cisplatin-based chemotherapy (NAC) related changes in molecular subtype and immune infiltration.
    Funt, Samuel Aaron
    Solovyov, Alexander
    Faltas, Bishoy Morris
    Iyer, Gopa
    Boyd, Mariel Elena
    Cipolla, Catharine Kline
    Regazzi, Ashley Marie
    Teo, Min Yuen
    Lee, Chung-Han
    Al-Ahmadie, Hikmat
    Rosenberg, Jonathan E.
    Greenbaum, Benjamin
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [50] FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.
    Sridhar, Srikala S.
    Power, Nicholas
    Breau, Rodney H.
    Cheng, Susanna Y.
    Pond, Gregory Russell
    Chung, Peter W. M.
    Metser, Ur
    Levine, Mark Norman
    Mukherjee, Som D.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345